These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Three years' experience with the sorin pericarbon stentless prosthesis: mid-term results with three different implantation techniques. Nagy ZL; Bodi A; Len A; Balogh I; Peterffy A J Heart Valve Dis; 2005 Jan; 14(1):72-7. PubMed ID: 15700439 [TBL] [Abstract][Full Text] [Related]
8. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years. Hvass U; Baron F; Elsebaey A; Nguyen D; Flecher E J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593 [TBL] [Abstract][Full Text] [Related]
9. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis. Bach DS; Goldman B; Verrier E; Petracek M; Wood J; Goldman S; David TE; J Heart Valve Dis; 2004 Jan; 13(1):64-72; discussion 72. PubMed ID: 14765842 [TBL] [Abstract][Full Text] [Related]
10. Eight-year results after aortic valve replacement with the CryoLife-O'Brien Stentless Aortic Porcine Bioprosthesis. Martinovic I; Farah I; Everlien M; Lindemann S; Knez I; Wittlinger T; Greve H; Vogt P J Thorac Cardiovasc Surg; 2005 Sep; 130(3):777-82. PubMed ID: 16153928 [TBL] [Abstract][Full Text] [Related]
11. Impact of small valve size on hemodynamics and left ventricular mass regression with the Toronto SPV stentless aortic bioprosthesis. Bach DS; Goldman B; Verrier E; Petracek M; Wood J; Goldman S; David T; J Heart Valve Dis; 2002 Mar; 11(2):236-41. PubMed ID: 12000166 [TBL] [Abstract][Full Text] [Related]
12. Early hemodynamic results of the Shelhigh SuperStentless aortic bioprostheses. Cattaneo P; Bruno VD; Mariscalco G; Marchetti P; Ferrarese S; Salerno-Uriarte J; Sala A J Card Surg; 2007; 22(5):379-84. PubMed ID: 17803572 [TBL] [Abstract][Full Text] [Related]
13. Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis. Emery RW; Arom KV; Kshettry VR; Kroshus TJ; Von R; Kersten TE; Lillehei TJ; Nicoloff DM; Erickson CA J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S37-44. PubMed ID: 11843519 [TBL] [Abstract][Full Text] [Related]
14. Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study. Borger MA; Carson SM; Ivanov J; Rao V; Scully HE; Feindel CM; David TE Ann Thorac Surg; 2005 Dec; 80(6):2180-5. PubMed ID: 16305867 [TBL] [Abstract][Full Text] [Related]
16. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis. Mykén P; Bech-Hanssen O; Phipps B; Caidahl K J Heart Valve Dis; 2000 May; 9(3):415-22. PubMed ID: 10888100 [TBL] [Abstract][Full Text] [Related]
17. Twenty-year experience with the St Jude Medical mechanical valve prosthesis. Ikonomidis JS; Kratz JM; Crumbley AJ; Stroud MR; Bradley SM; Sade RM; Crawford FA J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2022-31. PubMed ID: 14688722 [TBL] [Abstract][Full Text] [Related]
18. Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up. Nyawo B; Graham R; Hunter S J Heart Valve Dis; 2007 Jan; 16(1):42-8. PubMed ID: 17315382 [TBL] [Abstract][Full Text] [Related]
19. Analysis of explants and causes of mortality during long-term follow-up of the Toronto stentless porcine valve. Shargall Y; Goldman B; Christakis G; David T; Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):106-12. PubMed ID: 11805958 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome. Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]